Thiazolidinedione use and risk of Parkinson’s disease in patients with type 2 diabetes mellitus

The health burden of Parkinson’s disease (PD) and diabetes increases rapidly in China. However, no population-based study of the association between glucose lowering agents and PD incidence has been conducted in mainland Chinese population. Preclinical studies indicate that thiazolidinediones (TZDs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Houyu, Zhuo, Lin, Sun, Yexiang, Shen, Peng, Lin, Hongbo, Zhan, Siyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587207/
https://www.ncbi.nlm.nih.gov/pubmed/36271052
http://dx.doi.org/10.1038/s41531-022-00406-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587207/
https://www.ncbi.nlm.nih.gov/pubmed/36271052
http://dx.doi.org/10.1038/s41531-022-00406-8

Ejemplares similares